Gosselies-based OncoDNA has begun a significant partnership in molecular diagnostics with US company CollabRx.
OncoDNA provides next-generation DNA sequencing tests for clinical use in cancer. The partnership, a first for company outside the US, is a multi-year agreement in which the data analytics company, which focuses on informing clinical decision-making in molecular medicine, will provide technology and content ressources to be used with OncoDNA’s cancer mutation panels.
